IN2014MN01911A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01911A
IN2014MN01911A IN1911MUN2014A IN2014MN01911A IN 2014MN01911 A IN2014MN01911 A IN 2014MN01911A IN 1911MUN2014 A IN1911MUN2014 A IN 1911MUN2014A IN 2014MN01911 A IN2014MN01911 A IN 2014MN01911A
Authority
IN
India
Prior art keywords
present
relates
ingenol derivatives
reactivators
terms
Prior art date
Application number
Other languages
English (en)
Inventor
Luiz Francisco Pianowski
Amilcar Tanuri
Original Assignee
Amazônia Fitomedicamentos Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BR102012004739A external-priority patent/BR102012004739A2/pt
Priority claimed from BR102012006549A external-priority patent/BR102012006549A2/pt
Application filed by Amazônia Fitomedicamentos Ltda filed Critical Amazônia Fitomedicamentos Ltda
Publication of IN2014MN01911A publication Critical patent/IN2014MN01911A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G8/00Condensation polymers of aldehydes or ketones with phenols only
    • C08G8/28Chemically modified polycondensates
    • C08G8/30Chemically modified polycondensates by unsaturated compounds, e.g. terpenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
IN1911MUN2014 2012-03-02 2013-03-01 IN2014MN01911A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BR102012004739A BR102012004739A2 (pt) 2012-03-02 2012-03-02 uso de um ou mais derivados de ingenol, associação farmacêutica, composição farmacêutica, adjuvante, método de travamento e método para a reativação do vírus hiv latente
BR102012006549A BR102012006549A2 (pt) 2012-03-23 2012-03-23 uso de um ou mais derivados de ingenol, associação farmacêutica, composição farmacêutica, adjuvante, método de tratamento e método para a reativação do vírus hiv latente
PCT/BR2013/000063 WO2013126980A1 (pt) 2012-03-02 2013-03-01 Derivados de ingenol na reativação de vírus hiv latente

Publications (1)

Publication Number Publication Date
IN2014MN01911A true IN2014MN01911A (enExample) 2015-07-10

Family

ID=49081479

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1911MUN2014 IN2014MN01911A (enExample) 2012-03-02 2013-03-01

Country Status (13)

Country Link
US (1) US10105339B2 (enExample)
EP (1) EP2821105B1 (enExample)
JP (1) JP6280510B2 (enExample)
CN (1) CN104136081B (enExample)
AU (1) AU2013225633B2 (enExample)
CA (1) CA2864995C (enExample)
ES (1) ES2683726T3 (enExample)
IL (1) IL234404A (enExample)
IN (1) IN2014MN01911A (enExample)
MX (1) MX359300B (enExample)
NZ (1) NZ628408A (enExample)
RU (1) RU2609512C2 (enExample)
WO (1) WO2013126980A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102012028120B8 (pt) * 2012-11-01 2022-08-02 Amazonia Fitomedicamentos Ltda Uso de um ou mais derivados de ingenol, composição farmacêutica e medicamento
WO2016022358A1 (en) 2014-08-08 2016-02-11 The Regents Of The University Of California Compositions and methods for reactivating latent viral infections
WO2016177833A1 (en) 2015-05-04 2016-11-10 Bionor Immuno As Dosage regimen for hiv vaccine
WO2016191836A1 (pt) * 2015-06-03 2016-12-08 Amazônia Fitomedicamentos Ltda. Método de preparação de ingenol-3-dodecanoato, método de preparação de 3-etinil-3-hidroxi-4.7.7-trimetilbiciclo[4.1.0]heptano-2-carbaldeído e método de preparação de 2,2-dimetil-4-etinil-5-trifenilfosforanilideno-1,3-dioxano
WO2016191837A1 (pt) * 2015-06-03 2016-12-08 Amazônia Fitomedicamentos Ltda. Método de preparação de ingenol-3-hexanoato, método de preparação de 3-etinil-3-hidroxi-4.7.7-trimetilbiciclo[4.1.0]heptano-2-carbaldeído e método de preparação do composto 2,2-dimetil-4-etinil-5-trifenilfosforanilideno-1,3-dioxano
CN105079323B (zh) * 2015-09-15 2019-08-23 北京工业大学 几种中药提取物在hiv潜伏再激活治疗中的应用
CN106928063B (zh) * 2015-12-31 2020-09-01 上海鑫昊生物科技有限公司 巨大戟二萜醇类化合物及其在抗hiv潜伏治疗上的应用
WO2017130156A1 (en) 2016-01-27 2017-08-03 Glaxosmithkline Intellectual Property (No.2) Limited Ingenol analogs, pharmaceutical compositions and methods of use thereof
CN109912419A (zh) * 2017-12-13 2019-06-21 复旦大学 巨大戟烷型二萜及其在制备抗艾滋病毒药物中的用途
CN110251495B (zh) * 2018-03-12 2022-05-31 重庆医科大学 20-脱氧巨大戟二萜醇在制备抑制hbv复制的药物中的应用
EP3917946A4 (en) * 2019-01-28 2022-10-26 Xyphos Biosciences Inc. MODIFIED NKG2D NON-NATURAL LIGANDS THAT DELIVER SELECTIVELY BOUND HETEROLOGOUS MOLECULES TO NON-NATURAL NKG2D RECEPTORS ON CAR CELLS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07165600A (ja) 1993-10-18 1995-06-27 Souyaku Gijutsu Kenkyusho:Kk 抗ウイルス剤
JP2003171349A (ja) * 2001-08-06 2003-06-20 Univ Nihon 新規なジテルペン類、及びこれを用いた組成物、抗炎症剤、抗癌剤
WO2006116897A1 (fr) * 2005-04-30 2006-11-09 Nihon University Diterpenes provenant de euphorbia kansui et leur utilisation
AU2005333828A1 (en) * 2005-06-28 2007-01-04 Amazonia Fitomedicamentos Ltda Active fraction of a polar solvent extract from the latex of euphorbiaceae plants
US9895334B2 (en) * 2007-04-30 2018-02-20 Leo Laboratories Limited Treatment of virally induced lesions
WO2011086424A1 (en) * 2010-01-15 2011-07-21 Amazonia Fitomedicamentos Ltda Pharmaceutical use of multicyclic compounds mixtures as concomitant anti-cancer, anti-inflammatory and anti-pain agents
JP2013517262A (ja) * 2010-01-15 2013-05-16 アマゾニア・フイートメデイカメントス・リミタダ 抗エイズ剤としての多環式化合物の医薬的使用

Also Published As

Publication number Publication date
WO2013126980A1 (pt) 2013-09-06
JP6280510B2 (ja) 2018-02-14
EP2821105A1 (en) 2015-01-07
EP2821105B1 (en) 2018-05-23
US20150030638A1 (en) 2015-01-29
AU2013225633B2 (en) 2017-11-23
IL234404A (en) 2017-09-28
ES2683726T3 (es) 2018-09-27
EP2821105A4 (en) 2015-11-04
RU2609512C2 (ru) 2017-02-02
MX359300B (es) 2018-09-21
JP2015508782A (ja) 2015-03-23
RU2014139825A (ru) 2016-04-20
EP2821105A8 (en) 2015-04-29
CN104136081B (zh) 2018-05-15
HK1203872A1 (en) 2015-11-06
CA2864995C (en) 2016-12-06
US10105339B2 (en) 2018-10-23
AU2013225633A1 (en) 2014-08-28
CN104136081A (zh) 2014-11-05
NZ628408A (en) 2017-09-29
MX2014010463A (es) 2014-10-13
CA2864995A1 (en) 2013-09-06

Similar Documents

Publication Publication Date Title
IN2014MN01911A (enExample)
AU341275S (en) Flask
AU338648S (en) Packaging
AU338647S (en) Packaging
TWD163155S (zh) 耳機
TR201816986T4 (tr) Terapötik ajan iletim formülasyonlarına yönelik lipitler.
UA115311C2 (uk) Геміфумарат тенофовіру алафенаміду
CO6821908A2 (es) Prenda absorbente desechable que tiene superficies coloreadas y una pretina integral
AU340081S (en) Mug
SI2935303T1 (sl) 4'-fluoro-nukleozidi, 4'-fluoro-nukleotidi in njihovi analogi za zdravljenje HCV
AU352425S (en) Hand tightened hydraulic fitting
AU340078S (en) Tray
AU343911S (en) Animal garment
CL2015001055A1 (es) Composiciones para lavado de ropa; y uso de dicha composicion.
AU339376S (en) Sterilizing case
AU342423S (en) Combined cover and saucer
AU333457S (en) Flask
AU341603S (en) Washer
AU348863S (en) Divided party tray
PH12014502577A1 (en) Compositions comprising an anti-pdgf aptamer and a vegf antagonist
BR112014028458A2 (pt) papelão e bloco bruto de papelão.
AU342436S (en) Teapot
ES2543850R2 (es) Uso de complejos metálicos miméticos de SOD como agentes alimentarios y como cosméticos
TWD175860S (zh) 碳粉匣之部分
TWD176133S (zh) 碳粉匣之部分